Clinical trials
Completed Multiple Sclerosis trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
126 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 2 |
| 2006 | 5 |
| 2007 | 8 |
| 2008 | 8 |
| 2009 | 6 |
| 2010 | 5 |
| 2011 | 5 |
| 2012 | 4 |
| 2013 | 12 |
| 2014 | 5 |
| 2015 | 9 |
| 2016 | 6 |
| 2017 | 3 |
| 2018 | 9 |
| 2019 | 4 |
| 2020 | 3 |
| 2021 | 6 |
| 2022 | 4 |
| 2023 | 4 |
| 2024 | 9 |
| 2025 | 6 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 126 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Biogen | 13 |
| Novartis Pharmaceuticals | 12 |
| Bayer | 6 |
| Sanofi | 6 |
| Hoffmann-La Roche | 5 |
| Teva Branded Pharmaceutical Products R&D, Inc. | 5 |
| Actelion | 4 |
| Genzyme, a Sanofi Company | 4 |
| Merck KGaA, Darmstadt, Germany | 4 |
| EMD Serono Research & Development Institute, Inc. | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Sclerosis | 126 |
| Multiple Sclerosis, Relapsing-Remitting | 19 |
| Recurrence | 10 |
| Fatigue | 5 |
| Multiple Sclerosis, Chronic Progressive | 4 |
| Nervous System Diseases | 4 |
| Demyelinating Diseases | 3 |
| Autoimmune Diseases | 2 |
| Cognitive Dysfunction | 2 |
| Gait Disorders, Neurologic | 2 |
Trials
Showing 1 to 25 of 126. Each trial links to its page on Pharma Observatory.
26 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.